

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of action potential (GO:0045760) | 8.97295832 |
| 2 | tachykinin receptor signaling pathway (GO:0007217) | 8.68961976 |
| 3 | positive regulation of digestive system process (GO:0060456) | 7.01207448 |
| 4 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 6.23189476 |
| 5 | negative regulation of heart rate (GO:0010459) | 6.19390676 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 6.08150310 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 6.08150310 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.08150310 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 5.91991347 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.66507271 |
| 11 | L-phenylalanine catabolic process (GO:0006559) | 5.66507271 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.60461942 |
| 13 | regulation of action potential (GO:0098900) | 5.29664178 |
| 14 | L-phenylalanine metabolic process (GO:0006558) | 5.21079354 |
| 15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.21079354 |
| 16 | regulation of glucocorticoid secretion (GO:2000849) | 5.19751148 |
| 17 | kynurenine metabolic process (GO:0070189) | 5.17615594 |
| 18 | angiotensin maturation (GO:0002003) | 5.16690137 |
| 19 | positive regulation of steroid hormone secretion (GO:2000833) | 5.06503444 |
| 20 | bile acid biosynthetic process (GO:0006699) | 4.81081244 |
| 21 | amine catabolic process (GO:0009310) | 4.65227098 |
| 22 | cellular biogenic amine catabolic process (GO:0042402) | 4.65227098 |
| 23 | indolalkylamine metabolic process (GO:0006586) | 4.64686011 |
| 24 | positive regulation of renal sodium excretion (GO:0035815) | 4.61209580 |
| 25 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.43776774 |
| 26 | aromatic amino acid family metabolic process (GO:0009072) | 4.37085945 |
| 27 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.36679854 |
| 28 | regulation of fibrinolysis (GO:0051917) | 4.27884263 |
| 29 | regulation of guanylate cyclase activity (GO:0031282) | 4.22460782 |
| 30 | behavioral response to nicotine (GO:0035095) | 4.20130954 |
| 31 | negative regulation of lipase activity (GO:0060192) | 4.17671478 |
| 32 | regulation of corticosteroid hormone secretion (GO:2000846) | 4.14963730 |
| 33 | NAD biosynthetic process (GO:0009435) | 4.08801604 |
| 34 | imidazole-containing compound metabolic process (GO:0052803) | 4.07482910 |
| 35 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.06666623 |
| 36 | auditory receptor cell differentiation (GO:0042491) | 4.05851942 |
| 37 | high-density lipoprotein particle remodeling (GO:0034375) | 4.05685992 |
| 38 | bile acid metabolic process (GO:0008206) | 4.05118824 |
| 39 | nucleobase catabolic process (GO:0046113) | 4.01951678 |
| 40 | N-acetylneuraminate metabolic process (GO:0006054) | 3.96689038 |
| 41 | lipoprotein transport (GO:0042953) | 3.95160869 |
| 42 | glyoxylate metabolic process (GO:0046487) | 3.95099144 |
| 43 | epithelial cilium movement (GO:0003351) | 3.91736652 |
| 44 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.90976034 |
| 45 | regulation of cholesterol esterification (GO:0010872) | 3.90775093 |
| 46 | phospholipid efflux (GO:0033700) | 3.78277630 |
| 47 | presynaptic membrane organization (GO:0097090) | 3.77951993 |
| 48 | complement activation, alternative pathway (GO:0006957) | 3.77242733 |
| 49 | regulation of protein activation cascade (GO:2000257) | 3.72894603 |
| 50 | alpha-linolenic acid metabolic process (GO:0036109) | 3.69640158 |
| 51 | urea cycle (GO:0000050) | 3.67681441 |
| 52 | urea metabolic process (GO:0019627) | 3.67681441 |
| 53 | tyrosine metabolic process (GO:0006570) | 3.66106373 |
| 54 | very long-chain fatty acid metabolic process (GO:0000038) | 3.65498827 |
| 55 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.63583728 |
| 56 | presynaptic membrane assembly (GO:0097105) | 3.62526595 |
| 57 | protein carboxylation (GO:0018214) | 3.60541069 |
| 58 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.60541069 |
| 59 | triglyceride homeostasis (GO:0070328) | 3.59506374 |
| 60 | acylglycerol homeostasis (GO:0055090) | 3.59506374 |
| 61 | bile acid and bile salt transport (GO:0015721) | 3.58019697 |
| 62 | blood coagulation, intrinsic pathway (GO:0007597) | 3.57138001 |
| 63 | low-density lipoprotein particle remodeling (GO:0034374) | 3.55549234 |
| 64 | cellular glucuronidation (GO:0052695) | 3.55295348 |
| 65 | linoleic acid metabolic process (GO:0043651) | 3.54334127 |
| 66 | protein-lipid complex remodeling (GO:0034368) | 3.53986332 |
| 67 | macromolecular complex remodeling (GO:0034367) | 3.53986332 |
| 68 | plasma lipoprotein particle remodeling (GO:0034369) | 3.53986332 |
| 69 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.53872879 |
| 70 | negative regulation of fibrinolysis (GO:0051918) | 3.52573913 |
| 71 | coenzyme catabolic process (GO:0009109) | 3.52104791 |
| 72 | regulation of digestive system process (GO:0044058) | 3.50960710 |
| 73 | reverse cholesterol transport (GO:0043691) | 3.47916356 |
| 74 | cilium movement (GO:0003341) | 3.45141451 |
| 75 | nitrogen cycle metabolic process (GO:0071941) | 3.44673995 |
| 76 | serine family amino acid catabolic process (GO:0009071) | 3.44638623 |
| 77 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.43849191 |
| 78 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.43849191 |
| 79 | glomerulus development (GO:0032835) | 3.43482402 |
| 80 | benzene-containing compound metabolic process (GO:0042537) | 3.41536840 |
| 81 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.41426704 |
| 82 | regulation of complement activation (GO:0030449) | 3.40698354 |
| 83 | uronic acid metabolic process (GO:0006063) | 3.40589046 |
| 84 | glucuronate metabolic process (GO:0019585) | 3.40589046 |
| 85 | fatty acid elongation (GO:0030497) | 3.40293818 |
| 86 | cholesterol efflux (GO:0033344) | 3.39762354 |
| 87 | amino-acid betaine metabolic process (GO:0006577) | 3.38339971 |
| 88 | axonemal dynein complex assembly (GO:0070286) | 3.37625219 |
| 89 | epoxygenase P450 pathway (GO:0019373) | 3.37501904 |
| 90 | alpha-amino acid catabolic process (GO:1901606) | 3.36784736 |
| 91 | fat-soluble vitamin catabolic process (GO:0042363) | 3.34137180 |
| 92 | vitamin catabolic process (GO:0009111) | 3.34137180 |
| 93 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.32279950 |
| 94 | vitamin A metabolic process (GO:0006776) | 3.30366532 |
| 95 | regulation of triglyceride catabolic process (GO:0010896) | 3.30358397 |
| 96 | fucose catabolic process (GO:0019317) | 3.26937470 |
| 97 | L-fucose metabolic process (GO:0042354) | 3.26937470 |
| 98 | L-fucose catabolic process (GO:0042355) | 3.26937470 |
| 99 | indole-containing compound metabolic process (GO:0042430) | 3.26095822 |
| 100 | cellular ketone body metabolic process (GO:0046950) | 3.23146934 |
| 101 | homocysteine metabolic process (GO:0050667) | 3.18797536 |
| 102 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.15678213 |
| 103 | neuronal stem cell maintenance (GO:0097150) | 3.14067405 |
| 104 | long-term memory (GO:0007616) | 3.13581322 |
| 105 | intestinal absorption (GO:0050892) | 3.10948871 |
| 106 | neuron fate determination (GO:0048664) | 3.10533319 |
| 107 | glycerol metabolic process (GO:0006071) | 3.09410241 |
| 108 | regulation of phospholipase A2 activity (GO:0032429) | 3.08750274 |
| 109 | regulation of steroid hormone secretion (GO:2000831) | 3.08224206 |
| 110 | negative regulation of sterol transport (GO:0032372) | 3.07864899 |
| 111 | negative regulation of cholesterol transport (GO:0032375) | 3.07864899 |
| 112 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.07165038 |
| 113 | opsonization (GO:0008228) | 3.05931346 |
| 114 | drinking behavior (GO:0042756) | 3.05680202 |
| 115 | cellular amino acid catabolic process (GO:0009063) | 3.05519922 |
| 116 | fat-soluble vitamin metabolic process (GO:0006775) | 3.03756353 |
| 117 | aldehyde catabolic process (GO:0046185) | 3.03128950 |
| 118 | sulfation (GO:0051923) | 3.03034474 |
| 119 | alkaloid metabolic process (GO:0009820) | 3.02687610 |
| 120 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.02545376 |
| 121 | transepithelial transport (GO:0070633) | 3.01327615 |
| 122 | transmission of nerve impulse (GO:0019226) | 3.01219251 |
| 123 | regulation of pigment cell differentiation (GO:0050932) | 3.01204714 |
| 124 | response to auditory stimulus (GO:0010996) | 3.00766385 |
| 125 | neuronal action potential propagation (GO:0019227) | 2.99577757 |
| 126 | fibrinolysis (GO:0042730) | 2.98653881 |
| 127 | protein activation cascade (GO:0072376) | 2.94818990 |
| 128 | phenol-containing compound catabolic process (GO:0019336) | 2.94576798 |
| 129 | cytolysis (GO:0019835) | 2.90958955 |
| 130 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.89239541 |
| 131 | drug transmembrane transport (GO:0006855) | 2.88321258 |
| 132 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.87941538 |
| 133 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.87941538 |
| 134 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.87652072 |
| 135 | regulation of renal sodium excretion (GO:0035813) | 2.84655618 |
| 136 | drug metabolic process (GO:0017144) | 2.84593274 |
| 137 | plasma lipoprotein particle assembly (GO:0034377) | 2.83615569 |
| 138 | negative regulation of gene silencing (GO:0060969) | 2.83609201 |
| 139 | sulfur amino acid catabolic process (GO:0000098) | 2.81751279 |
| 140 | vitamin biosynthetic process (GO:0009110) | 2.81569993 |
| 141 | axonal fasciculation (GO:0007413) | 2.80447791 |
| 142 | mechanoreceptor differentiation (GO:0042490) | 2.80254344 |
| 143 | androgen biosynthetic process (GO:0006702) | 2.79869729 |
| 144 | cysteine metabolic process (GO:0006534) | 2.78886064 |
| 145 | retinal ganglion cell axon guidance (GO:0031290) | 2.78474637 |
| 146 | arginine metabolic process (GO:0006525) | 2.75914678 |
| 147 | plasma lipoprotein particle organization (GO:0071827) | 2.75866941 |
| 148 | ketone body metabolic process (GO:1902224) | 2.75141163 |
| 149 | carboxylic acid catabolic process (GO:0046395) | 2.75113202 |
| 150 | organic acid catabolic process (GO:0016054) | 2.75113202 |
| 151 | neurotransmitter catabolic process (GO:0042135) | 2.74609436 |
| 152 | glutamate metabolic process (GO:0006536) | 2.74177326 |
| 153 | neuronal action potential (GO:0019228) | 2.74152465 |
| 154 | startle response (GO:0001964) | 2.73240663 |
| 155 | nucleotide transmembrane transport (GO:1901679) | 2.71938257 |
| 156 | alditol metabolic process (GO:0019400) | 2.70993463 |
| 157 | cofactor catabolic process (GO:0051187) | 2.69465461 |
| 158 | complement activation, classical pathway (GO:0006958) | 2.69033289 |
| 159 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.68170246 |
| 160 | endocrine process (GO:0050886) | 2.68170246 |
| 161 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.68170246 |
| 162 | somite development (GO:0061053) | 2.67147311 |
| 163 | negative regulation of heart contraction (GO:0045822) | 2.66406998 |
| 164 | drug catabolic process (GO:0042737) | 2.65133845 |
| 165 | serotonin metabolic process (GO:0042428) | 2.64967550 |
| 166 | flavonoid metabolic process (GO:0009812) | 2.64940533 |
| 167 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.64486287 |
| 168 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.64058608 |
| 169 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.64058608 |
| 170 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.61095667 |
| 171 | positive regulation of mitochondrial fission (GO:0090141) | 2.61092543 |
| 172 | complement activation (GO:0006956) | 2.60904912 |
| 173 | pyridine-containing compound biosynthetic process (GO:0072525) | 2.60092693 |
| 174 | sensory perception of pain (GO:0019233) | 2.58845863 |
| 175 | regulation of excretion (GO:0044062) | 2.58769891 |
| 176 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.58646072 |
| 177 | sulfate transport (GO:0008272) | 2.57716768 |
| 178 | cellular anion homeostasis (GO:0030002) | 2.56979020 |
| 179 | neuron recognition (GO:0008038) | 2.56362279 |
| 180 | response to pain (GO:0048265) | 2.55595604 |
| 181 | androgen metabolic process (GO:0008209) | 2.55533728 |
| 182 | diacylglycerol metabolic process (GO:0046339) | 2.54451355 |
| 183 | retinal rod cell development (GO:0046548) | 2.54350624 |
| 184 | regulation of systemic arterial blood pressure (GO:0003073) | 2.53704145 |
| 185 | quinone biosynthetic process (GO:1901663) | 2.53203788 |
| 186 | synapse assembly (GO:0007416) | 2.52633411 |
| 187 | regulation of cGMP biosynthetic process (GO:0030826) | 2.51426780 |
| 188 | regulation of bile acid biosynthetic process (GO:0070857) | 2.50519711 |
| 189 | synaptic transmission, glutamatergic (GO:0035249) | 2.48513786 |
| 190 | peristalsis (GO:0030432) | 2.48489672 |
| 191 | axon ensheathment in central nervous system (GO:0032291) | 2.48233622 |
| 192 | central nervous system myelination (GO:0022010) | 2.48233622 |
| 193 | primary amino compound metabolic process (GO:1901160) | 2.47042957 |
| 194 | positive regulation of vesicle fusion (GO:0031340) | 2.46968315 |
| 195 | kidney morphogenesis (GO:0060993) | 2.46919277 |
| 196 | sulfate transmembrane transport (GO:1902358) | 2.45103403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.03488696 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.72924652 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.50251509 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.98906270 |
| 5 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.97499058 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.46068348 |
| 7 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.40381042 |
| 8 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.36222216 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.25236358 |
| 10 | FUS_26573619_Chip-Seq_HEK293_Human | 2.23087569 |
| 11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.17068258 |
| 12 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.17023755 |
| 13 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.14031311 |
| 14 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.92910872 |
| 15 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.91436590 |
| 16 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.90605511 |
| 17 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.88825000 |
| 18 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.86855134 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.83543806 |
| 20 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.83515115 |
| 21 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.80698936 |
| 22 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.79856838 |
| 23 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.79624895 |
| 24 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.78915408 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.77650858 |
| 26 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.77285502 |
| 27 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.71853033 |
| 28 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.70875880 |
| 29 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.70021487 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.69971117 |
| 31 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.69223464 |
| 32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.68483577 |
| 33 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.67877661 |
| 34 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.66820096 |
| 35 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.63447610 |
| 36 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.63255733 |
| 37 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.61520559 |
| 38 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.61520559 |
| 39 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.61099667 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60755140 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.60433760 |
| 42 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.60055553 |
| 43 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.57997491 |
| 44 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.55413322 |
| 45 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.55384645 |
| 46 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.53690682 |
| 47 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.51410416 |
| 48 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.51220802 |
| 49 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.50892461 |
| 50 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.50563861 |
| 51 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.49033936 |
| 52 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.48511083 |
| 53 | EWS_26573619_Chip-Seq_HEK293_Human | 1.48248215 |
| 54 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.47993455 |
| 55 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.47437929 |
| 56 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.47267447 |
| 57 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.46989763 |
| 58 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.46624612 |
| 59 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.45303701 |
| 60 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.44023244 |
| 61 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.42970201 |
| 62 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.42429677 |
| 63 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.38667772 |
| 64 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.38487588 |
| 65 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.36652973 |
| 66 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.36179745 |
| 67 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.34193144 |
| 68 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.33757740 |
| 69 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.33751225 |
| 70 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.33384068 |
| 71 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.33278424 |
| 72 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.32564340 |
| 73 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.31234598 |
| 74 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.30703179 |
| 75 | VDR_22108803_ChIP-Seq_LS180_Human | 1.29732772 |
| 76 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.29698989 |
| 77 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28543649 |
| 78 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.27848896 |
| 79 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.27793790 |
| 80 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26097478 |
| 81 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.25579474 |
| 82 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.24964730 |
| 83 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.24670555 |
| 84 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.23992775 |
| 85 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.23736652 |
| 86 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.23675590 |
| 87 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.21606630 |
| 88 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21447082 |
| 89 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.19620302 |
| 90 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.19346989 |
| 91 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.19264611 |
| 92 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.19220261 |
| 93 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.18216560 |
| 94 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.18132038 |
| 95 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17735021 |
| 96 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.17735021 |
| 97 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.17319335 |
| 98 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.17126080 |
| 99 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.17096746 |
| 100 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.16809895 |
| 101 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.16625178 |
| 102 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16091072 |
| 103 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.15385083 |
| 104 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.14952946 |
| 105 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.14590770 |
| 106 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.13985908 |
| 107 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.13014885 |
| 108 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10749508 |
| 109 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.09021323 |
| 110 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.08772785 |
| 111 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08767815 |
| 112 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.08312846 |
| 113 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.07205477 |
| 114 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.06636626 |
| 115 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.06370278 |
| 116 | STAT3_23295773_ChIP-Seq_U87_Human | 1.05791016 |
| 117 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05562361 |
| 118 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04843995 |
| 119 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.04265482 |
| 120 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.04243001 |
| 121 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.04242957 |
| 122 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.04242957 |
| 123 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04190061 |
| 124 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04105274 |
| 125 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.04071329 |
| 126 | KDM2B_26808549_Chip-Seq_REH_Human | 1.03863777 |
| 127 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03181769 |
| 128 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.02627720 |
| 129 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.02604701 |
| 130 | RXR_22108803_ChIP-Seq_LS180_Human | 1.02355604 |
| 131 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.01559293 |
| 132 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.00769037 |
| 133 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00082497 |
| 134 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.99931963 |
| 135 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99109706 |
| 136 | AR_25329375_ChIP-Seq_VCAP_Human | 0.99069920 |
| 137 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.98984265 |
| 138 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.98123148 |
| 139 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.97775938 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.17011675 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 5.07230297 |
| 3 | MP0005360_urolithiasis | 4.87202638 |
| 4 | MP0005365_abnormal_bile_salt | 4.49716882 |
| 5 | MP0004381_abnormal_hair_follicle | 3.77336336 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.55133213 |
| 7 | MP0004270_analgesia | 3.01818257 |
| 8 | MP0003183_abnormal_peptide_metabolism | 2.84711269 |
| 9 | MP0003252_abnormal_bile_duct | 2.75305235 |
| 10 | MP0003195_calcinosis | 2.62479836 |
| 11 | MP0003136_yellow_coat_color | 2.56259508 |
| 12 | MP0004147_increased_porphyrin_level | 2.38466405 |
| 13 | MP0001188_hyperpigmentation | 2.29892677 |
| 14 | MP0004859_abnormal_synaptic_plasticity | 2.29323252 |
| 15 | MP0009697_abnormal_copulation | 2.28650787 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.27484688 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.26322790 |
| 18 | MP0002876_abnormal_thyroid_physiology | 2.15702445 |
| 19 | MP0005075_abnormal_melanosome_morpholog | 2.06055619 |
| 20 | MP0002653_abnormal_ependyma_morphology | 2.01935013 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 1.90625127 |
| 22 | MP0005451_abnormal_body_composition | 1.88990715 |
| 23 | MP0003868_abnormal_feces_composition | 1.88573436 |
| 24 | MP0005645_abnormal_hypothalamus_physiol | 1.84889976 |
| 25 | MP0006292_abnormal_olfactory_placode | 1.79858124 |
| 26 | MP0005332_abnormal_amino_acid | 1.75722547 |
| 27 | MP0004885_abnormal_endolymph | 1.74159382 |
| 28 | MP0005409_darkened_coat_color | 1.69370230 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 1.69167745 |
| 30 | MP0001485_abnormal_pinna_reflex | 1.67844831 |
| 31 | MP0003011_delayed_dark_adaptation | 1.66292020 |
| 32 | MP0000566_synostosis | 1.66187791 |
| 33 | MP0001970_abnormal_pain_threshold | 1.60368887 |
| 34 | MP0005670_abnormal_white_adipose | 1.59491472 |
| 35 | MP0003880_abnormal_central_pattern | 1.58131872 |
| 36 | MP0006276_abnormal_autonomic_nervous | 1.55402075 |
| 37 | MP0001666_abnormal_nutrient_absorption | 1.55252438 |
| 38 | MP0000372_irregular_coat_pigmentation | 1.51218825 |
| 39 | MP0004133_heterotaxia | 1.51201728 |
| 40 | MP0005408_hypopigmentation | 1.50096648 |
| 41 | MP0001756_abnormal_urination | 1.47722256 |
| 42 | MP0005083_abnormal_biliary_tract | 1.44347080 |
| 43 | MP0001764_abnormal_homeostasis | 1.41430087 |
| 44 | MP0005647_abnormal_sex_gland | 1.35904747 |
| 45 | MP0004142_abnormal_muscle_tone | 1.34664117 |
| 46 | MP0002118_abnormal_lipid_homeostasis | 1.34597017 |
| 47 | * MP0003635_abnormal_synaptic_transmissio | 1.33588307 |
| 48 | * MP0001486_abnormal_startle_reflex | 1.31101106 |
| 49 | MP0005646_abnormal_pituitary_gland | 1.29801753 |
| 50 | MP0002254_reproductive_system_inflammat | 1.27647951 |
| 51 | MP0002063_abnormal_learning/memory/cond | 1.26906107 |
| 52 | MP0009379_abnormal_foot_pigmentation | 1.26222654 |
| 53 | MP0003787_abnormal_imprinting | 1.24952289 |
| 54 | MP0000538_abnormal_urinary_bladder | 1.24731436 |
| 55 | MP0009046_muscle_twitch | 1.22041463 |
| 56 | MP0001968_abnormal_touch/_nociception | 1.21592461 |
| 57 | MP0000569_abnormal_digit_pigmentation | 1.21471195 |
| 58 | MP0005551_abnormal_eye_electrophysiolog | 1.20878445 |
| 59 | MP0005174_abnormal_tail_pigmentation | 1.17651431 |
| 60 | MP0009764_decreased_sensitivity_to | 1.17270101 |
| 61 | MP0002736_abnormal_nociception_after | 1.16220684 |
| 62 | MP0004782_abnormal_surfactant_physiolog | 1.15888279 |
| 63 | MP0001440_abnormal_grooming_behavior | 1.14974273 |
| 64 | MP0002102_abnormal_ear_morphology | 1.14972059 |
| 65 | MP0002909_abnormal_adrenal_gland | 1.10457447 |
| 66 | MP0000955_abnormal_spinal_cord | 1.09462055 |
| 67 | MP0005423_abnormal_somatic_nervous | 1.08191030 |
| 68 | MP0001502_abnormal_circadian_rhythm | 1.07719072 |
| 69 | MP0001984_abnormal_olfaction | 1.06905120 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 1.04880880 |
| 71 | MP0002733_abnormal_thermal_nociception | 1.02194225 |
| 72 | MP0001348_abnormal_lacrimal_gland | 1.02040833 |
| 73 | MP0003119_abnormal_digestive_system | 0.99574361 |
| 74 | MP0003283_abnormal_digestive_organ | 0.99457051 |
| 75 | MP0009840_abnormal_foam_cell | 0.98982961 |
| 76 | MP0005377_hearing/vestibular/ear_phenot | 0.97584331 |
| 77 | MP0003878_abnormal_ear_physiology | 0.97584331 |
| 78 | MP0005379_endocrine/exocrine_gland_phen | 0.97491612 |
| 79 | MP0003718_maternal_effect | 0.96058630 |
| 80 | MP0000609_abnormal_liver_physiology | 0.95657664 |
| 81 | MP0000049_abnormal_middle_ear | 0.94346298 |
| 82 | MP0002638_abnormal_pupillary_reflex | 0.93054851 |
| 83 | MP0004858_abnormal_nervous_system | 0.92914116 |
| 84 | MP0003122_maternal_imprinting | 0.92799886 |
| 85 | MP0008872_abnormal_physiological_respon | 0.90833689 |
| 86 | * MP0002882_abnormal_neuron_morphology | 0.90540986 |
| 87 | MP0002928_abnormal_bile_duct | 0.89554463 |
| 88 | MP0001664_abnormal_digestion | 0.88871264 |
| 89 | * MP0000026_abnormal_inner_ear | 0.88404345 |
| 90 | MP0000015_abnormal_ear_pigmentation | 0.88233930 |
| 91 | MP0008260_abnormal_autophagy | 0.87043343 |
| 92 | MP0004924_abnormal_behavior | 0.86482482 |
| 93 | MP0005386_behavior/neurological_phenoty | 0.86482482 |
| 94 | MP0002160_abnormal_reproductive_system | 0.85920694 |
| 95 | MP0000230_abnormal_systemic_arterial | 0.84438432 |
| 96 | * MP0002184_abnormal_innervation | 0.83509792 |
| 97 | * MP0009745_abnormal_behavioral_response | 0.83379515 |
| 98 | MP0003938_abnormal_ear_development | 0.83289694 |
| 99 | MP0002735_abnormal_chemical_nociception | 0.82548437 |
| 100 | MP0002067_abnormal_sensory_capabilities | 0.81721417 |
| 101 | MP0005448_abnormal_energy_balance | 0.80233800 |
| 102 | MP0001501_abnormal_sleep_pattern | 0.80023916 |
| 103 | MP0000579_abnormal_nail_morphology | 0.79883367 |
| 104 | MP0001765_abnormal_ion_homeostasis | 0.79768636 |
| 105 | MP0005319_abnormal_enzyme/_coenzyme | 0.79521695 |
| 106 | MP0005395_other_phenotype | 0.79439190 |
| 107 | MP0002132_abnormal_respiratory_system | 0.79352511 |
| 108 | MP0004145_abnormal_muscle_electrophysio | 0.79231487 |
| 109 | * MP0002752_abnormal_somatic_nervous | 0.79221006 |
| 110 | MP0006072_abnormal_retinal_apoptosis | 0.78409595 |
| 111 | MP0003191_abnormal_cellular_cholesterol | 0.77283464 |
| 112 | MP0002572_abnormal_emotion/affect_behav | 0.76967430 |
| 113 | MP0002751_abnormal_autonomic_nervous | 0.76963220 |
| 114 | MP0004043_abnormal_pH_regulation | 0.76731265 |
| 115 | MP0002249_abnormal_larynx_morphology | 0.76480951 |
| 116 | MP0002069_abnormal_eating/drinking_beha | 0.75498575 |
| 117 | MP0001919_abnormal_reproductive_system | 0.75464327 |
| 118 | MP0001986_abnormal_taste_sensitivity | 0.75312068 |
| 119 | MP0005171_absent_coat_pigmentation | 0.74879165 |
| 120 | MP0001905_abnormal_dopamine_level | 0.74251216 |
| 121 | MP0002822_catalepsy | 0.73303949 |
| 122 | MP0002152_abnormal_brain_morphology | 0.72657479 |
| 123 | * MP0003879_abnormal_hair_cell | 0.71960815 |
| 124 | MP0002557_abnormal_social/conspecific_i | 0.71758671 |
| 125 | MP0003121_genomic_imprinting | 0.71625360 |
| 126 | * MP0002272_abnormal_nervous_system | 0.70571552 |
| 127 | * MP0001963_abnormal_hearing_physiology | 0.69366116 |
| 128 | MP0005187_abnormal_penis_morphology | 0.68513594 |
| 129 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.67307726 |
| 130 | MP0003724_increased_susceptibility_to | 0.67168435 |
| 131 | MP0005535_abnormal_body_temperature | 0.66375993 |
| 132 | MP0003690_abnormal_glial_cell | 0.65691444 |
| 133 | MP0005084_abnormal_gallbladder_morpholo | 0.64273812 |
| 134 | MP0005248_abnormal_Harderian_gland | 0.62476316 |
| 135 | MP0000778_abnormal_nervous_system | 0.60903471 |
| 136 | MP0002168_other_aberrant_phenotype | 0.59495910 |
| 137 | MP0002734_abnormal_mechanical_nocicepti | 0.59032548 |
| 138 | MP0010386_abnormal_urinary_bladder | 0.58802395 |
| 139 | MP0001346_abnormal_lacrimal_gland | 0.58720061 |
| 140 | MP0001529_abnormal_vocalization | 0.58561240 |
| 141 | MP0009765_abnormal_xenobiotic_induced | 0.58444312 |
| 142 | MP0000631_abnormal_neuroendocrine_gland | 0.58391404 |
| 143 | MP0005636_abnormal_mineral_homeostasis | 0.58025786 |
| 144 | * MP0002064_seizures | 0.57130828 |
| 145 | MP0004742_abnormal_vestibular_system | 0.56350521 |
| 146 | MP0005253_abnormal_eye_physiology | 0.55160126 |
| 147 | MP0009763_increased_sensitivity_to | 0.54619706 |
| 148 | MP0009642_abnormal_blood_homeostasis | 0.54118996 |
| 149 | MP0005389_reproductive_system_phenotype | 0.52473420 |
| 150 | MP0003186_abnormal_redox_activity | 0.50659720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 6.27047407 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.61347623 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.03385367 |
| 4 | Joint hemorrhage (HP:0005261) | 4.82648604 |
| 5 | Deep venous thrombosis (HP:0002625) | 4.32622153 |
| 6 | Conjugated hyperbilirubinemia (HP:0002908) | 4.23530744 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.12401414 |
| 8 | Polyphagia (HP:0002591) | 3.96844027 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 3.80990040 |
| 10 | Confusion (HP:0001289) | 3.78907355 |
| 11 | Hydroxyprolinuria (HP:0003080) | 3.68853405 |
| 12 | Abnormality of proline metabolism (HP:0010907) | 3.68853405 |
| 13 | Xanthomatosis (HP:0000991) | 3.66018705 |
| 14 | Epidermoid cyst (HP:0200040) | 3.58472024 |
| 15 | Complement deficiency (HP:0004431) | 3.55730839 |
| 16 | Renal cortical cysts (HP:0000803) | 3.53902399 |
| 17 | Hyperlipoproteinemia (HP:0010980) | 3.53565147 |
| 18 | Genetic anticipation (HP:0003743) | 3.43984873 |
| 19 | Abnormality of vitamin B metabolism (HP:0004340) | 3.41717505 |
| 20 | Vascular calcification (HP:0004934) | 3.41103096 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 3.40782275 |
| 22 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.34453132 |
| 23 | Osteomalacia (HP:0002749) | 3.32183527 |
| 24 | Nephronophthisis (HP:0000090) | 3.21046155 |
| 25 | True hermaphroditism (HP:0010459) | 3.13781478 |
| 26 | Hyperglycinemia (HP:0002154) | 3.08680366 |
| 27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.03359715 |
| 28 | Fat malabsorption (HP:0002630) | 2.99642604 |
| 29 | Hypochromic microcytic anemia (HP:0004840) | 2.97442184 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.97413692 |
| 31 | Pancreatic cysts (HP:0001737) | 2.96376251 |
| 32 | Hypophosphatemic rickets (HP:0004912) | 2.96033427 |
| 33 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.93570393 |
| 34 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.93570393 |
| 35 | Molar tooth sign on MRI (HP:0002419) | 2.92736216 |
| 36 | Abnormality of midbrain morphology (HP:0002418) | 2.92736216 |
| 37 | Abnormal eating behavior (HP:0100738) | 2.90162748 |
| 38 | Fibular aplasia (HP:0002990) | 2.89211435 |
| 39 | Agitation (HP:0000713) | 2.88849019 |
| 40 | Pancreatic fibrosis (HP:0100732) | 2.84593452 |
| 41 | Abnormality of the corticospinal tract (HP:0002492) | 2.84109305 |
| 42 | Enlarged kidneys (HP:0000105) | 2.84061285 |
| 43 | Cardiovascular calcification (HP:0011915) | 2.81441401 |
| 44 | 3-Methylglutaconic aciduria (HP:0003535) | 2.77824364 |
| 45 | Hypolipoproteinemia (HP:0010981) | 2.76795990 |
| 46 | Progressive cerebellar ataxia (HP:0002073) | 2.75349385 |
| 47 | Chorioretinal atrophy (HP:0000533) | 2.74353392 |
| 48 | Abnormal ciliary motility (HP:0012262) | 2.73002641 |
| 49 | Rhinitis (HP:0012384) | 2.72508546 |
| 50 | Abnormality of the common coagulation pathway (HP:0010990) | 2.69879166 |
| 51 | Medial flaring of the eyebrow (HP:0010747) | 2.64679561 |
| 52 | Fair hair (HP:0002286) | 2.64434397 |
| 53 | Abnormality of the renal medulla (HP:0100957) | 2.64245999 |
| 54 | Decreased circulating renin level (HP:0003351) | 2.64094240 |
| 55 | Proximal tubulopathy (HP:0000114) | 2.63832467 |
| 56 | Action tremor (HP:0002345) | 2.62631171 |
| 57 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.58733317 |
| 58 | Synostosis involving the elbow (HP:0003938) | 2.56814174 |
| 59 | Humeroradial synostosis (HP:0003041) | 2.56814174 |
| 60 | Tubulointerstitial nephritis (HP:0001970) | 2.52995381 |
| 61 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.52993935 |
| 62 | Rickets (HP:0002748) | 2.52954854 |
| 63 | Hyperglycinuria (HP:0003108) | 2.50606015 |
| 64 | Hypoalphalipoproteinemia (HP:0003233) | 2.47688979 |
| 65 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.45946428 |
| 66 | Abnormality of vitamin metabolism (HP:0100508) | 2.45576168 |
| 67 | Chronic hepatic failure (HP:0100626) | 2.45570855 |
| 68 | Abnormality of complement system (HP:0005339) | 2.45112091 |
| 69 | Gait imbalance (HP:0002141) | 2.43352895 |
| 70 | Bile duct proliferation (HP:0001408) | 2.42556982 |
| 71 | Abnormal biliary tract physiology (HP:0012439) | 2.42556982 |
| 72 | Short tibia (HP:0005736) | 2.41441354 |
| 73 | Hyperammonemia (HP:0001987) | 2.40262332 |
| 74 | Abnormality of glycine metabolism (HP:0010895) | 2.40206923 |
| 75 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.40206923 |
| 76 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.34896794 |
| 77 | Hip dysplasia (HP:0001385) | 2.34435110 |
| 78 | Hyperventilation (HP:0002883) | 2.33347893 |
| 79 | Parakeratosis (HP:0001036) | 2.32279917 |
| 80 | Cystic liver disease (HP:0006706) | 2.32276932 |
| 81 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.30258876 |
| 82 | Decreased central vision (HP:0007663) | 2.29641067 |
| 83 | Hypercholesterolemia (HP:0003124) | 2.29558367 |
| 84 | Broad-based gait (HP:0002136) | 2.28603590 |
| 85 | Ketosis (HP:0001946) | 2.27690327 |
| 86 | Abolished electroretinogram (ERG) (HP:0000550) | 2.27062013 |
| 87 | Steatorrhea (HP:0002570) | 2.25779162 |
| 88 | Abnormality of serum amino acid levels (HP:0003112) | 2.25485804 |
| 89 | Abnormality of the intrinsic pathway (HP:0010989) | 2.25134859 |
| 90 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.24629310 |
| 91 | Hyperbilirubinemia (HP:0002904) | 2.23422833 |
| 92 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.23236788 |
| 93 | Hypoglycemic coma (HP:0001325) | 2.20161104 |
| 94 | Rib fusion (HP:0000902) | 2.18525130 |
| 95 | Congenital primary aphakia (HP:0007707) | 2.17755894 |
| 96 | Pigmentary retinal degeneration (HP:0001146) | 2.17495685 |
| 97 | Amyloidosis (HP:0011034) | 2.17431031 |
| 98 | Metabolic alkalosis (HP:0200114) | 2.15227518 |
| 99 | Hyperphosphaturia (HP:0003109) | 2.13463696 |
| 100 | Prolonged neonatal jaundice (HP:0006579) | 2.12539471 |
| 101 | Febrile seizures (HP:0002373) | 2.11616605 |
| 102 | Delayed CNS myelination (HP:0002188) | 2.11303475 |
| 103 | Hepatoblastoma (HP:0002884) | 2.10861074 |
| 104 | Metabolic acidosis (HP:0001942) | 2.10133343 |
| 105 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.08040826 |
| 106 | Myokymia (HP:0002411) | 2.05996550 |
| 107 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.02368520 |
| 108 | Limb dystonia (HP:0002451) | 2.02183312 |
| 109 | Nephrogenic diabetes insipidus (HP:0009806) | 2.01824209 |
| 110 | Abnormality of renal resorption (HP:0011038) | 2.00345644 |
| 111 | Abnormality of urine glucose concentration (HP:0011016) | 2.00138256 |
| 112 | Glycosuria (HP:0003076) | 2.00138256 |
| 113 | Systemic lupus erythematosus (HP:0002725) | 1.99735226 |
| 114 | Widely patent fontanelles and sutures (HP:0004492) | 1.99341320 |
| 115 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.97888686 |
| 116 | Absent/shortened dynein arms (HP:0200106) | 1.97888686 |
| 117 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.96561462 |
| 118 | Renal Fanconi syndrome (HP:0001994) | 1.95825526 |
| 119 | Abnormality of secondary sexual hair (HP:0009888) | 1.95510152 |
| 120 | Abnormality of the axillary hair (HP:0100134) | 1.95510152 |
| 121 | Reduced antithrombin III activity (HP:0001976) | 1.95427325 |
| 122 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.94450249 |
| 123 | Mitral stenosis (HP:0001718) | 1.94332254 |
| 124 | Abnormality of the renal cortex (HP:0011035) | 1.92832474 |
| 125 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.92771760 |
| 126 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.92600467 |
| 127 | Ulnar claw (HP:0001178) | 1.91612326 |
| 128 | Blue irides (HP:0000635) | 1.90980235 |
| 129 | Abnormality of nucleobase metabolism (HP:0010932) | 1.90282795 |
| 130 | Aplasia/Hypoplasia of the ulna (HP:0006495) | 1.89139072 |
| 131 | Gingival bleeding (HP:0000225) | 1.88315173 |
| 132 | Generalized hypopigmentation of hair (HP:0011358) | 1.86971667 |
| 133 | Vaginal atresia (HP:0000148) | 1.85886523 |
| 134 | Opisthotonus (HP:0002179) | 1.85062333 |
| 135 | Genital tract atresia (HP:0001827) | 1.85004652 |
| 136 | Renal tubular dysfunction (HP:0000124) | 1.84891216 |
| 137 | Hypoglycemic seizures (HP:0002173) | 1.84819953 |
| 138 | Hemiparesis (HP:0001269) | 1.83532094 |
| 139 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.83046827 |
| 140 | Adactyly (HP:0009776) | 1.82709099 |
| 141 | Hypoplasia of the ulna (HP:0003022) | 1.81755740 |
| 142 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.81531497 |
| 143 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.81531497 |
| 144 | Alveolar cell carcinoma (HP:0006519) | 1.81183220 |
| 145 | Megaloblastic anemia (HP:0001889) | 1.80926702 |
| 146 | Chronic diarrhea (HP:0002028) | 1.80626128 |
| 147 | Abnormality of the 1st metacarpal (HP:0010009) | 1.80371707 |
| 148 | Anencephaly (HP:0002323) | 1.80358540 |
| 149 | Specific learning disability (HP:0001328) | 1.79718051 |
| 150 | Lethargy (HP:0001254) | 1.79137028 |
| 151 | Sclerocornea (HP:0000647) | 1.78801337 |
| 152 | Postaxial hand polydactyly (HP:0001162) | 1.78657833 |
| 153 | Focal motor seizures (HP:0011153) | 1.78167156 |
| 154 | Hepatocellular carcinoma (HP:0001402) | 1.77989485 |
| 155 | Hypothermia (HP:0002045) | 1.77911797 |
| 156 | Malnutrition (HP:0004395) | 1.77450578 |
| 157 | Glomerulonephritis (HP:0000099) | 1.77254509 |
| 158 | Abnormal urine phosphate concentration (HP:0012599) | 1.77250444 |
| 159 | Menorrhagia (HP:0000132) | 1.75055420 |
| 160 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.74926456 |
| 161 | Methylmalonic acidemia (HP:0002912) | 1.74740130 |
| 162 | Status epilepticus (HP:0002133) | 1.73895170 |
| 163 | Cerebral edema (HP:0002181) | 1.73888218 |
| 164 | Alkalosis (HP:0001948) | 1.73725778 |
| 165 | Spontaneous abortion (HP:0005268) | 1.73403792 |
| 166 | Poor coordination (HP:0002370) | 1.73205778 |
| 167 | Nephrolithiasis (HP:0000787) | 1.72460297 |
| 168 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.72440184 |
| 169 | Congenital sensorineural hearing impairment (HP:0008527) | 1.72387099 |
| 170 | Occipital encephalocele (HP:0002085) | 1.71487551 |
| 171 | Methylmalonic aciduria (HP:0012120) | 1.70954624 |
| 172 | Elevated alkaline phosphatase (HP:0003155) | 1.70766545 |
| 173 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.70157710 |
| 174 | Short 1st metacarpal (HP:0010034) | 1.70157710 |
| 175 | Septo-optic dysplasia (HP:0100842) | 1.69353866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.65117100 |
| 2 | MAP3K4 | 3.46016563 |
| 3 | INSRR | 3.18798426 |
| 4 | ACVR1B | 2.90249555 |
| 5 | STK16 | 2.77481574 |
| 6 | TNIK | 2.56973310 |
| 7 | IRAK3 | 2.46013248 |
| 8 | MUSK | 2.44213407 |
| 9 | ZAK | 2.17862972 |
| 10 | YES1 | 2.08865280 |
| 11 | IRAK4 | 2.03381151 |
| 12 | BLK | 1.98518491 |
| 13 | TAOK3 | 1.88676564 |
| 14 | MKNK2 | 1.82232128 |
| 15 | GRK1 | 1.76331285 |
| 16 | WNK4 | 1.75011734 |
| 17 | IRAK1 | 1.67867695 |
| 18 | PIK3CG | 1.67274691 |
| 19 | IRAK2 | 1.66359224 |
| 20 | ADRBK2 | 1.66241702 |
| 21 | BMPR2 | 1.63908330 |
| 22 | MAP3K14 | 1.63628784 |
| 23 | DYRK3 | 1.60307583 |
| 24 | PINK1 | 1.57015010 |
| 25 | MAP2K7 | 1.56778962 |
| 26 | MAPK15 | 1.53832703 |
| 27 | FGFR4 | 1.49455977 |
| 28 | GRK7 | 1.45597686 |
| 29 | MARK1 | 1.43063959 |
| 30 | EIF2AK2 | 1.42105670 |
| 31 | MAPK13 | 1.40175700 |
| 32 | NTRK3 | 1.34032229 |
| 33 | TXK | 1.33610283 |
| 34 | PKN1 | 1.33034423 |
| 35 | BCKDK | 1.24228375 |
| 36 | MAP4K2 | 1.20595046 |
| 37 | DYRK1B | 1.19740768 |
| 38 | SIK3 | 1.17938868 |
| 39 | EPHA3 | 1.15116076 |
| 40 | EPHA4 | 1.14137246 |
| 41 | BMPR1B | 1.13074271 |
| 42 | ERBB4 | 1.07475819 |
| 43 | EPHB2 | 1.05824597 |
| 44 | FLT3 | 1.04557164 |
| 45 | PKN2 | 1.04525928 |
| 46 | TNK2 | 1.04006491 |
| 47 | CDK3 | 1.03704087 |
| 48 | PRPF4B | 1.01158195 |
| 49 | PRKG2 | 1.00327101 |
| 50 | MAP2K4 | 0.99980089 |
| 51 | WNK3 | 0.99739543 |
| 52 | SGK2 | 0.97960055 |
| 53 | CSNK1G1 | 0.96998608 |
| 54 | SIK1 | 0.96107114 |
| 55 | CSNK1A1L | 0.95739988 |
| 56 | CDK19 | 0.94822751 |
| 57 | MAPK4 | 0.92548951 |
| 58 | RPS6KA4 | 0.91255556 |
| 59 | NEK6 | 0.90786703 |
| 60 | CDK5 | 0.90308309 |
| 61 | PRKCZ | 0.87929635 |
| 62 | ERBB3 | 0.87736277 |
| 63 | SRPK1 | 0.85420320 |
| 64 | CSNK1G3 | 0.84337514 |
| 65 | CSNK1G2 | 0.79306375 |
| 66 | ERBB2 | 0.78543976 |
| 67 | MAPK7 | 0.78436085 |
| 68 | DYRK1A | 0.77302444 |
| 69 | SGK494 | 0.77146637 |
| 70 | SGK223 | 0.77146637 |
| 71 | UHMK1 | 0.77012965 |
| 72 | CAMK2A | 0.76540636 |
| 73 | STK38L | 0.76503105 |
| 74 | NTRK2 | 0.75070222 |
| 75 | MAPKAPK3 | 0.74429841 |
| 76 | PAK3 | 0.74043893 |
| 77 | AKT3 | 0.72065231 |
| 78 | MKNK1 | 0.71722806 |
| 79 | SIK2 | 0.71589488 |
| 80 | PNCK | 0.70815548 |
| 81 | TYRO3 | 0.69989243 |
| 82 | MST1R | 0.69302503 |
| 83 | CAMK2G | 0.69153846 |
| 84 | CAMK2B | 0.65539484 |
| 85 | TAOK1 | 0.65530112 |
| 86 | PBK | 0.65461383 |
| 87 | PRKCG | 0.65293983 |
| 88 | PRKCE | 0.63219195 |
| 89 | PRKCQ | 0.63196506 |
| 90 | MAP3K9 | 0.62814302 |
| 91 | TAOK2 | 0.61722668 |
| 92 | TEC | 0.60654000 |
| 93 | FES | 0.60460619 |
| 94 | CAMK2D | 0.60147178 |
| 95 | PRKACG | 0.57864684 |
| 96 | EPHB1 | 0.57135759 |
| 97 | PRKAA2 | 0.56259230 |
| 98 | OXSR1 | 0.55782608 |
| 99 | TGFBR2 | 0.55408271 |
| 100 | NTRK1 | 0.54247167 |
| 101 | BCR | 0.54035516 |
| 102 | DYRK2 | 0.54034801 |
| 103 | GRK5 | 0.53492881 |
| 104 | STK39 | 0.52935161 |
| 105 | CSK | 0.52529960 |
| 106 | PAK6 | 0.52280401 |
| 107 | CSNK1A1 | 0.49993512 |
| 108 | ROCK1 | 0.49926129 |
| 109 | PIK3CA | 0.49736044 |
| 110 | PRKACA | 0.49503532 |
| 111 | ABL2 | 0.49306137 |
| 112 | LYN | 0.48912490 |
| 113 | DAPK2 | 0.48480441 |
| 114 | PRKG1 | 0.46136755 |
| 115 | STK24 | 0.45908072 |
| 116 | MAP2K6 | 0.44998611 |
| 117 | MAPK11 | 0.44982425 |
| 118 | MAP3K13 | 0.44856725 |
| 119 | FGR | 0.44834339 |
| 120 | RPS6KA2 | 0.44786582 |
| 121 | NLK | 0.43284739 |
| 122 | JAK1 | 0.43238796 |
| 123 | CAMK1 | 0.42968062 |
| 124 | NUAK1 | 0.42697971 |
| 125 | MAP3K10 | 0.42421262 |
| 126 | IKBKE | 0.41323193 |
| 127 | MAP3K12 | 0.41281714 |
| 128 | SGK1 | 0.41266831 |
| 129 | PRKCA | 0.40655796 |
| 130 | PLK4 | 0.39732678 |
| 131 | MAPK12 | 0.39361521 |
| 132 | FRK | 0.38672988 |
| 133 | TIE1 | 0.38644788 |
| 134 | HCK | 0.38491542 |
| 135 | ADRBK1 | 0.37982679 |
| 136 | PTK2B | 0.36611875 |
| 137 | FYN | 0.36560600 |
| 138 | PLK2 | 0.34693425 |
| 139 | TGFBR1 | 0.31705136 |
| 140 | GSK3A | 0.29911264 |
| 141 | TLK1 | 0.29312319 |
| 142 | PRKAA1 | 0.28942621 |
| 143 | PRKACB | 0.27891737 |
| 144 | PRKD2 | 0.26765958 |
| 145 | PRKCB | 0.25832128 |
| 146 | SGK3 | 0.25385976 |
| 147 | RPS6KA6 | 0.24902520 |
| 148 | CDK11A | 0.23561068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.33444856 |
| 2 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.49392919 |
| 3 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.74163594 |
| 4 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66015347 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.63162704 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.61299200 |
| 7 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.52881211 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.50567018 |
| 9 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.36762633 |
| 10 | Retinol metabolism_Homo sapiens_hsa00830 | 2.36573902 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 2.35261875 |
| 12 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.24257711 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.16088740 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.15906281 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.12887412 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.12318684 |
| 17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.07500339 |
| 18 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.05935910 |
| 19 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.03150455 |
| 20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.02830427 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.01675236 |
| 22 | Mineral absorption_Homo sapiens_hsa04978 | 1.97965732 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.95500403 |
| 24 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.86265342 |
| 25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.85701479 |
| 26 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.82087545 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.80698594 |
| 28 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.72491758 |
| 29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.72359171 |
| 30 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.72004512 |
| 31 | ABC transporters_Homo sapiens_hsa02010 | 1.70962958 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.68977118 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.66554599 |
| 34 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.65367148 |
| 35 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.63239452 |
| 36 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.62387962 |
| 37 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.50090215 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.48637577 |
| 39 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.47473671 |
| 40 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.46095797 |
| 41 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.46017112 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.45598428 |
| 43 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.45519796 |
| 44 | Galactose metabolism_Homo sapiens_hsa00052 | 1.45258048 |
| 45 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.30113474 |
| 46 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.30092103 |
| 47 | Parkinsons disease_Homo sapiens_hsa05012 | 1.28797781 |
| 48 | Insulin secretion_Homo sapiens_hsa04911 | 1.27169465 |
| 49 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.26664677 |
| 50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.17590286 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14155583 |
| 52 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.13040518 |
| 53 | Bile secretion_Homo sapiens_hsa04976 | 1.04119586 |
| 54 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.01303080 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.00926855 |
| 56 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.00356143 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99658142 |
| 58 | * Nicotine addiction_Homo sapiens_hsa05033 | 0.98283126 |
| 59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.94145931 |
| 60 | Alzheimers disease_Homo sapiens_hsa05010 | 0.94145186 |
| 61 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.91968691 |
| 62 | Huntingtons disease_Homo sapiens_hsa05016 | 0.91333876 |
| 63 | Phototransduction_Homo sapiens_hsa04744 | 0.90472203 |
| 64 | Circadian entrainment_Homo sapiens_hsa04713 | 0.90174204 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88248130 |
| 66 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.86695977 |
| 67 | Axon guidance_Homo sapiens_hsa04360 | 0.84769386 |
| 68 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.82684848 |
| 69 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.82632645 |
| 70 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.82576918 |
| 71 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.80989542 |
| 72 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.79413791 |
| 73 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.72424344 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.69959436 |
| 75 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.65310634 |
| 76 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.64987021 |
| 77 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.64159760 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.63500959 |
| 79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.63162419 |
| 80 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.58021132 |
| 81 | Lysine degradation_Homo sapiens_hsa00310 | 0.57783220 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.55395642 |
| 83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54815335 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54670878 |
| 85 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54616529 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.51562600 |
| 87 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.49446209 |
| 88 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.49119393 |
| 89 | Taste transduction_Homo sapiens_hsa04742 | 0.46854545 |
| 90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46695800 |
| 91 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.46590174 |
| 92 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.46093301 |
| 93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43792325 |
| 94 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.41839158 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41465001 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40712028 |
| 97 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.40229396 |
| 98 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.40058427 |
| 99 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.39679020 |
| 100 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.39598861 |
| 101 | Gap junction_Homo sapiens_hsa04540 | 0.39275626 |
| 102 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.38858549 |
| 103 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.38565803 |
| 104 | Morphine addiction_Homo sapiens_hsa05032 | 0.37944877 |
| 105 | Olfactory transduction_Homo sapiens_hsa04740 | 0.37830947 |
| 106 | GABAergic synapse_Homo sapiens_hsa04727 | 0.37123690 |
| 107 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36675766 |
| 108 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.33963017 |
| 109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.33590245 |
| 110 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.31194668 |
| 111 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.30317211 |
| 112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29399009 |
| 113 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.29174045 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.28787323 |
| 115 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.28518071 |
| 116 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.27946984 |
| 117 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.26940116 |
| 118 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.26796573 |
| 119 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.26445904 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.26184163 |
| 121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23699007 |
| 122 | Sulfur relay system_Homo sapiens_hsa04122 | 0.20881575 |
| 123 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 0.20315549 |
| 124 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.20009281 |
| 125 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.17180226 |
| 126 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.13938092 |
| 127 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.12797177 |
| 128 | Allograft rejection_Homo sapiens_hsa05330 | 0.10170100 |
| 129 | Protein export_Homo sapiens_hsa03060 | 0.10094087 |
| 130 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.09799334 |
| 131 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.08622137 |
| 132 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.08250373 |
| 133 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.05040760 |

